Loading clinical trials...
Loading clinical trials...
Evaluation of the Safety and Effectiveness of the GORE® Tissue Reinforcement for Breast Reconstruction Device (TRBR Device) When Used in the Reinforcement of Breast Reconstruction
The GORE Tissue Reinforcement for Breast Reconstruction (TRBR) research study will look at breast reconstruction during mastectomy procedures. There will be two arms in this study, a Treatment Arm, where data will be collected for a new medical device called the Tissue Reinforcement for Breast Reconstruction (TRBR) Device and a Control Arm where data will be collected from subjects who have previously had surgery and received no additional tissue reinforcement in their breast reconstruction surgery. This research study will look at the safety of the Study Device and the success of the participants breast reconstruction. The Study Device is investigational, which means it has not yet been used nor approved by the FDA for this treatment. The data collected in this study will be compared to the data collected in the Control Arm.
Age
22 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Mayo Clinic Arizona
Scottsdale, Arizona, United States
University of Arizona
Tucson, Arizona, United States
The Regents of the University of California
Irvine, California, United States
Cedars-Sinai Plastic and Reconstruction Surgery
Los Angeles, California, United States
Riverside University Health System-Medical Center
Moreno Valley, California, United States
Mayo Clinic Florida
Jacksonville, Florida, United States
Endeavor Health (Northshore University HealthSystem Research Institute)
Evanston, Illinois, United States
Northwestern University
Evanston, Illinois, United States
BR Hope LLC
Wichita, Kansas, United States
The Johns Hopkins University
Baltimore, Maryland, United States
Start Date
April 9, 2025
Primary Completion Date
July 1, 2027
Completion Date
July 1, 2030
Last Updated
October 23, 2025
180
ESTIMATED participants
TRBR Device
DEVICE
Lead Sponsor
W.L.Gore & Associates
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions